| Accord Healthcare AG - Fulvestrant Accord 250 mg / 5 ml, Injektionslösung in einer Fertigspritze |
| 67565 | | 01 | | Fulvestrant Accord 250 mg / 5 ml | | Injektionslösung in einer Fertigspritze | | L02BA03 | | Fulvestrant | | 11.08.2020 | | |
|
| Composition |
| fulvestrantum 250 mg, ethanolum 96 per centum 500 mg, alcohol benzylicus 500 mg, benzylis benzoas 750 mg, ricini oleum raffinatum, q.s. ad solutionem pro 5 ml. |
| Packungsbestandteile |
| Solution injectable en seringue prête à l'emploi | | | | | | | | Principe actif | Concentr. |
|---|
| Fulvestrant | 250mg / 5ml |
| | BAG: Principe actif | Concentr. |
|---|
| Fulvestrant | 250 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Alcohol Benzylicus | 500mg / 5ml | | Benzyl Benzoate | 750mg / 5ml | | Ethanolum 96 Per Centum | 500mg / 5ml | | Ricini Oleum Raffinate | |
| |
|
|
